U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C14H9ClF3NO3
Molecular Weight 331.674
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 8-HYDROXYEFAVIRENZ

SMILES

OC1=CC(Cl)=CC2=C1NC(=O)O[C@]2(C#CC3CC3)C(F)(F)F

InChI

InChIKey=OOVOMPCQLMFEDT-ZDUSSCGKSA-N
InChI=1S/C14H9ClF3NO3/c15-8-5-9-11(10(20)6-8)19-12(21)22-13(9,14(16,17)18)4-3-7-1-2-7/h5-7,20H,1-2H2,(H,19,21)/t13-/m0/s1

HIDE SMILES / InChI

Molecular Formula C14H9ClF3NO3
Molecular Weight 331.674
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor efavirenz.
2001 Mar 12
Substance Class Chemical
Created
by admin
on Sat Dec 16 09:29:38 UTC 2023
Edited
by admin
on Sat Dec 16 09:29:38 UTC 2023
Record UNII
P8S49CKH6L
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
8-HYDROXYEFAVIRENZ
Common Name English
(4S)-6-CHLORO-4-(2-CYCLOPROPYLETHYNYL)-8-HYDROXY-4-(TRIFLUOROMETHYL)-1H-3,1-BENZOXAZIN-2-ONE
Systematic Name English
2H-3,1-BENZOXAZIN-2-ONE, 6-CHLORO-4-(CYCLOPROPYLETHYNYL)-1,4-DIHYDRO-8-HYDROXY-4-(TRIFLUOROMETHYL)-, (4S)-
Systematic Name English
Code System Code Type Description
PUBCHEM
487643
Created by admin on Sat Dec 16 09:29:38 UTC 2023 , Edited by admin on Sat Dec 16 09:29:38 UTC 2023
PRIMARY
CAS
205754-33-2
Created by admin on Sat Dec 16 09:29:38 UTC 2023 , Edited by admin on Sat Dec 16 09:29:38 UTC 2023
PRIMARY
EPA CompTox
DTXSID50942769
Created by admin on Sat Dec 16 09:29:38 UTC 2023 , Edited by admin on Sat Dec 16 09:29:38 UTC 2023
PRIMARY
FDA UNII
P8S49CKH6L
Created by admin on Sat Dec 16 09:29:38 UTC 2023 , Edited by admin on Sat Dec 16 09:29:38 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE ACTIVE
THE MAJOR OXIDATIVE METABOLITE OF EFAVIRENZ IN VIVO AND IN VITRO HUMAN LIVER MICROSOMAL PREPARATIONS IS 8-HYDROXYEFAVIRENZ
MAJOR